Procalcitonin for Predicting Serious Bacterial Infection in Infants Less Than 3 Months (PRONOUR)

Assistance Publique - Hôpitaux de Paris

Status: Completed

Conditions: Fever; Bacterial Infection

Study type: Observational

Funder types: Other

Identifiers

NCT00800488

AOR 06 047

Details and patient eligibility

About

The primary objective is to study the value of serum procalcitonin as a predictive marker for severe bacterial infection in febrile infants.

2200 febrile infants aged less than 3 months will prospectively be included. All infants will have a measure of Procalcitonin concentrations. Comparison of the mean value of Procalcitonin concentration in infants with and without serious Bacterial infection.

Evaluation of the area under the ROC for Procalcitonin concentration.

Full description

Serious bacterial infections are often difficult to detect in infant with fever without source. Procalcitonin is a better blood marker of infection than White blood cell count and possibly than C-reactive protein. This could lead to a reduction in antibiotic prescription. Our objective is to evaluate the impact of Procalcitonin result on antibiotic prescription in children 1 to 3 month old with fever without source and our hypothesis is that it will lower the antibiotic prescription rate.

Enrollment: 2,209 patients

Sex: All

Ages: 7 days to 3 months old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Infant older than 7 days old and less than 3 months old.
• Fever (defined by a rectal temperature greater than or equal to 38°C)
• Emergency consultation

Exclusion criteria

• Infants with a previously identified immunodeficiency or chronic disease,
• Antibiotic treatment within the previous 48 hours